ALX Oncology (ALXO) Insider Trading & Ownership $0.55 +0.04 (+8.76%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$0.54 -0.01 (-1.87%) As of 04/15/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALX Oncology (NASDAQ:ALXO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage33.40%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$148,860.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$1.61 M Get ALXO Insider Trade Alerts Want to know when executives and insiders are buying or selling ALX Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALXO Insider Buying and Selling by Quarter Remove Ads ALX Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/6/2025Shelly PintoCFOSell2,221$1.80$3,997.80 12/30/2024Jaume PonsInsiderSell10,796$1.58$17,057.68 12/30/2024Shelly PintoCFOSell1,426$1.58$2,253.08 12/2/2024Rekha HemrajaniDirectorBuy30,000$1.55$46,500.00 8/14/2024Shelly PintoCAOSell564$2.58$1,455.12 8/14/2024Sophia RandolphInsiderSell1,365$2.58$3,521.70 7/11/2024Jaume PonsInsiderSell20,000$7.90$158,000.00 7/5/2024Shelly PintoCAOSell1,823$5.50$10,026.50 7/1/2024Shelly PintoCAOSell1,373$5.82$7,990.86 7/1/2024Sophia RandolphInsiderSell3,273$5.82$19,048.86 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/13/2024Peter S GarciaCFOBuy12,000$8.53$102,360.00 6/4/2024Jaume PonsInsiderSell20,000$8.43$168,600.00 5/13/2024Sophia RandolphInsiderSell12,000$15.94$191,280.00 5/6/2024Jaume PonsInsiderSell20,000$15.92$318,400.00 4/16/2024Jaume PonsInsiderSell50,000$14.20$710,000.00 (Data available from 1/1/2013 forward) ALXO Insider Trading Activity - Frequently Asked Questions Who is on ALX Oncology's Insider Roster? The list of insiders at ALX Oncology includes Jason Lettmann, Jaume Pons, Peter S Garcia, Rekha Hemrajani, Shelly Pinto, and Sophia Randolph. Learn more on insiders at ALXO. What percentage of ALX Oncology stock is owned by insiders? 33.40% of ALX Oncology stock is owned by insiders. Learn more on ALXO's insider holdings. Which ALX Oncology insiders have been buying company stock? The following insiders have purchased ALXO shares in the last 24 months: Jason Lettmann ($49,764.00), Peter S Garcia ($102,360.00), and Rekha Hemrajani ($46,500.00). How much insider buying is happening at ALX Oncology? Insiders have purchased a total of 46,400 ALXO shares in the last 24 months for a total of $198,624.00 bought. Which ALX Oncology insiders have been selling company stock? The following insiders have sold ALXO shares in the last 24 months: Jaume Pons ($1,618,604.40), Peter S Garcia ($6,510.58), Shelly Pinto ($113,984.40), and Sophia Randolph ($225,631.26). How much insider selling is happening at ALX Oncology? Insiders have sold a total of 181,069 ALX Oncology shares in the last 24 months for a total of $1,964,730.64 sold. ALX Oncology Key ExecutivesDr. Corey S. Goodman Ph.D. (Age 72)Executive Chairman Compensation: $84kMr. Jason W. Lettmann (Age 47)CEO & Director Compensation: $60.5kDr. Jaume Pons Ph.D. (Age 57)Founder, President, Director & Chief Scientific Officer Compensation: $856.29kMr. Peter S. Garcia M.B.A. (Age 62)Chief Financial Officer Compensation: $631.11kDr. Sophia Randolph M.D. (Age 56)Ph.D., Chief Medical Officer & Director Compensation: $637.24kDr. Michael Chang Ph.D.Vice President of OperationsMs. Shelly Pinto (Age 47)Senior VP of Finance & Chief Accounting Officer Compensation: $508.26k2 recent tradesDr. Christopher Byrd J.D.Ph.D., General CounselDr. Athanasios Tsiatis M.D.Senior Vice President of Clinical DevelopmentDr. Lin Yeong-Liang M.D.M.S., Senior Vice President of Drug Safety & Pharmacovigilance More Insider Trading Tools from MarketBeat Related Companies Nkarta Insider Buying Elutia Insider Buying Fate Therapeutics Insider Buying Alector Insider Buying Seres Therapeutics Insider Buying Enanta Pharmaceuticals Insider Buying FitLife Brands Insider Buying Coherus BioSciences Insider Buying C4 Therapeutics Insider Buying OptiNose Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1Casey’s General Stores Insider Buys Shares of This Must-Own Stock This page (NASDAQ:ALXO) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALXO Stock Free ALXO Stock Alerts